AtriCure provides innovative technologies for the treatment of Afib and related conditions. The Isolator® Synergy™ Ablation System is FDA approved for the treatment of persistent Afib. Hybrid AF™ Therapy with the EPi-Sense Device for the treatment of long-standing persistent Afib. The AtriClip LAA Exclusion System used during concomitant cardiac surgery worldwide.